<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rehab</journal-id><journal-title-group><journal-title xml:lang="ru">Реабилитология</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of Medical Rehabilitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2949-5873</issn><issn pub-type="epub">2949-5881</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2949-5873/rehabil.2024.26</article-id><article-id custom-type="elpub" pub-id-type="custom">rehab-44</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Динамическая оценка содержания маркеров воспаления в крови пациенток в периоде реабилитации после хирургического лечения наружного генитального эндометриоза</article-title><trans-title-group xml:lang="en"><trans-title>Dynamic assessment of blood inflammation markers in patients during the rehabilitation period after surgical treatment for external genital endometriosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0845-7550</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Байгалмаа</surname><given-names>Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Baigalmaa</surname><given-names>B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Байгалмаа Балдансамбуу </p><p>Улан-Батор</p></bio><bio xml:lang="en"><p>Baldansambuu Baigalmaa </p><p>Ulan Bator</p></bio><email xlink:type="simple">baikala1011@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8404-1042</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бицадзе</surname><given-names>В. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Bitsadze</surname><given-names>V. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бицадзе Виктория Омаровна, д.м.н., проф., проф. РАН</p><p>ул. Трубецкая, д. 8, стр. 2, Москва 119991</p><p>WoS ResearcherID: F-8409-2017. Scopus Author ID: 6506003478</p></bio><bio xml:lang="en"><p>Victoria O. Bitsadze, Dr. Sci. Med., Prof., Prof. of RAS</p><p>WoS ResearcherID: F-8409-2017. Scopus Author ID: 6506003478</p><p>8 bldg 2 Trubetskaya Str., Moscow 119991</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-6130-2434</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ефанов</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Efanov</surname><given-names>A. Е.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ефанов Александр Евгеньевич </p><p>ул. Саляма Адиля, д. 2/44, Москва 123423</p></bio><bio xml:lang="en"><p>Alexander E. Efanov </p><p>2/44 Salyam Adil Str., Moscow 123423</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4761-5793</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Войновский</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Voynovskiy</surname><given-names>A. Е.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Войновский Александр Евгеньевич, д.м.н., проф.</p><p>ул. Саляма Адиля, д. 2/44, Москва 123423</p><p>WoS ResearcherID: S-6385-2016</p></bio><bio xml:lang="en"><p>Alexander Е. Voynovskiy, Dr. Sci. Med., Prof.</p><p>WoS ResearcherID: S-6385-2016</p><p>2/44 Salyam Adil Str., Moscow 123423</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Клиника «Амгалан»</institution><country>Монголия</country></aff><aff xml:lang="en"><institution>Amgalan Hospital</institution><country>Mongolia</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное автономное образовательное учреждение высшего образования «Первый Московский государственный медицинский университет им. И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Государственное бюджетное учреждение здравоохранения г. Москвы «Городская клиническая больница № 67</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Vorokhobov City Clinical Hospital No. 67</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>04</day><month>02</month><year>2025</year></pub-date><volume>2</volume><issue>3</issue><fpage>286</fpage><lpage>294</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Байгалмаа Б., Бицадзе В.О., Ефанов А.Е., Войновский А.Е., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Байгалмаа Б., Бицадзе В.О., Ефанов А.Е., Войновский А.Е.</copyright-holder><copyright-holder xml:lang="en">Baigalmaa B., Bitsadze V.O., Efanov A.Е., Voynovskiy A.Е.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rehabilitology.com/jour/article/view/44">https://www.rehabilitology.com/jour/article/view/44</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. При оказании реабилитационной помощи женщинам с наружным генитальным эндометриозом (НГЭ), перенесшим хирургическое лечение, требуется междисциплинарный подход к подбору стратегии ведения пациенток и средств объективного контроля состояния их здоровья.</p></sec><sec><title>Цель</title><p>Цель: определить целесообразность использования биомаркеров воспаления у женщин, проходящих реабилитацию после хирургического лечения НГЭ, для оценки качества медицинской помощи.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В исследование были включены 40 пациенток с НГЭ (основная группа), 40 пациенток с другими гинекологическими патологиями (группа сравнения) и 40 почти здоровых женщин (контрольная группа). Все участни­цы с гинекологическими патологиями проходили хирургическое лечение с последующей реабилитацией. Выражен­ность воспалительного процесса оценивали по содержанию в сыворотке крови следующих биомаркеров воспаления: интерлейкин-6 (англ. interleukin 6, IL-6), фактор некроза опухоли альфа (англ. tumor necrosis factor alpha, TNF-a), цитруллинированный гистон Н3 (англ. citrullinated histone H3, CitH3) и отношение «нейтрофилы/лимфоциты» (англ. neutrophil to lymphocyte ratio, NLR). Динамику изменения уровней данных биомаркеров определяли до хирургического лечения, через 1 нед и через 3 мес после операции.</p></sec><sec><title>Результаты</title><p>Результаты. Оценка концентрации биомаркеров воспаления в сыворотке крови указала на наличие воспалительных процессов у больных основной группы и группы сравнения. В то же время уровни IL-6, TNF-a, CitH3 и NLR у пациенток с НГЭ были статистически значимо выше по сравнению с аналогичными показателями у женщин с другими гинеколо­гическими патологиями. Через 1 нед после хирургического вмешательства в основной группе отмечено существенное увеличение концентраций IL-6, CitH3 и NLR и уменьшение уровня TNF-a по отношению к исходным значениям. Через 3 мес после операции в основной группе наблюдалось значительное снижение выраженности воспалительного про­цесса по сравнению с показателями через 1 нед после лечения. При этом в ряде случаев уровни биомаркеров воспале­ния было статистически значимо ниже по сравнению с исходными значениями. Примечательно уменьшение сыворо­точной концентрации CitH3 до показателя у почти здоровых женщин.</p></sec><sec><title>Заключение</title><p>Заключение. У пациенток с НГЭ зарегистрировано течение воспалительного процесса, поддающееся коррекции путем хирургического вмешательства. Показана целесообразность использования сывороточной концентрацииCitH3 в качестве маркера контроля качества проведения оперативного лечения НГЭ и ведения пациенток на восста­новительном этапе.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Providing rehabilitation care to women with external genital endometriosis (EGE) after surgical treatment requires an interdisciplinary approach to selecting patient management strategy and biomarkers for objective monitoring of health status.</p></sec><sec><title>Objective</title><p>Objective: to determine the feasibility of using inflammatory biomarkers in women undergoing rehabilitation after EGE surgical treatment to assess the quality of care.</p></sec><sec><title>Material and methods</title><p>Material and methods. The study included 40 EGE patients (main group), 40 patients with other gynecological pathologies (comparison group), and 40 nearly healthy women (control group). All participants with gynecological pathologies underwent surgical treatment with subsequent rehabilitation. The severity of the inflammatory process was assessed using the following inflammation biomarkers: serum interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-a), citrullinated histone H3 (CitH3), and the neutrophil to lymphocyte ratio (NLR). The dynamics of changes in biomarker levels were measured before surgery, 1 week and 3 months after it.</p></sec><sec><title>Results</title><p>Results. The assessment of inflammatory biomarker serum concentrations indicated the presence of inflammatory processes in patients of both the main and comparison groups. However, the levels of IL-6, TNF-a, CitH3 and NLR among EGE patients were statistically significantly higher compared to similar parameters in women with other gynecological pathologies. One week after surgery, the main group showed a significant increase in concentrations of IL-6, CitH3 and NLR and a decrease in TNF-a levels compared to baseline values. Three months after surgery, a significant reduction in the severity of the inflammatory process in the main group was observed compared to the values obtained 1 week after surgery. In several cases, the levels of inflammatory biomarkers were statistically significantly lower than baseline values. Notably, the serum concentration of CitH3 decreased to levels observed in nearly healthy women.</p></sec><sec><title>Conclusion</title><p>Conclusion. An inflammatory process was recorded in EGE patients, which can be corrected through surgical intervention. Using serum concentrations of CitH3 as a marker for assessing the quality of surgical treatment for EGE and managing patients during the rehabilitation phase was proved to be viable.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>эндометриоз</kwd><kwd>наружный генитальный эндометриоз</kwd><kwd>реабилитация</kwd><kwd>воспаление</kwd><kwd>биомаркеры</kwd><kwd>интерлейкин-6</kwd><kwd>фактор некроза опухоли альфа</kwd><kwd>цитруллинированный гистон Н3</kwd><kwd>отношение «нейтрофилы/лимфоциты»</kwd></kwd-group><kwd-group xml:lang="en"><kwd>endometriosis</kwd><kwd>external genital endometriosis</kwd><kwd>rehabilitation</kwd><kwd>inflammation</kwd><kwd>biomarkers</kwd><kwd>interleukin-6</kwd><kwd>tumor necrosis factor alpha</kwd><kwd>citrullinated histone H3</kwd><kwd>neutrophil to lymphocyte ratio</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Солопова А.Г., Ачкасов Е.Е., Москвичёва В.С. и др. Наружный генитальный эндометриоз: вопросы лечения и реабилитации. Акушерство, гинекология и репродукция. 2021; 15 (1): 70-9. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.148.</mixed-citation><mixed-citation xml:lang="en">Solopova A.G., Achkasov E.E., Moskvichyova V.S., et al. External genital endometriosis: treatment and rehabilitation. Obstetrics, Gynecology and Reproduction. 2021; 15 (1): 70-9 (in Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.148.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Санджиева Л.Н., Галкин В.Н., Блинов Д.В., Солопова А.Г. Влияние реабилитации на качество жизни после радикального лечения рака эндометрия и атипической гиперплазии эндометрия. Реабилитология. 2024; 1 (1): 5-17. https://doi.org/10.17749/2949-5873/rehabil.2023.1.</mixed-citation><mixed-citation xml:lang="en">Sandzhieva L.N., Galkin V.N., Blinov D.V., Solopova A.G. The influence of rehabilitation on the quality of life after radical treatment of endometrial cancer and atypical endometrial hyperplasia. Reabilitologiya / Rehabilitology. 2024; 1 (1): 5-17 (in Russ.). https://doi.org/10.17749/2949-5873/rehabil.2023.1.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Eisenberg V.H., Weil C., Chodick G., Shalev V. Epidemiology of endometriosis: a large population-based database study from a healthcare provider with 2 million members. BJOG. 2018; 125 (1): 55-62. https://doi.org/10.1111/1471-0528.14711.</mixed-citation><mixed-citation xml:lang="en">Eisenberg V.H., Weil C., Chodick G., Shalev V. Epidemiology of endometriosis: a large population-based database study from a healthcare provider with 2 million members. BJOG. 2018; 125 (1): 55-62. https://doi.org/10.1111/1471-0528.14711.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Pugsley Z., Ballard K. Management of endometriosis in general practice: the pathway to diagnosis. Br J Gen Pract. 2007; 57 (539): 470-6.</mixed-citation><mixed-citation xml:lang="en">Pugsley Z., Ballard K. Management of endometriosis in general practice: the pathway to diagnosis. Br J Gen Pract. 2007; 57 (539): 470-6.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ballard K.D., Seaman H.E., de Vries C.S., Wright J.T. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study - Part 1. BJOG. 2008; 115 (11): 1382-91. https://doi.org/10.1111/j.1471-0528.2008.01878.x.</mixed-citation><mixed-citation xml:lang="en">Ballard K.D., Seaman H.E., de Vries C.S., Wright J.T. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study - Part 1. BJOG. 2008; 115 (11): 1382-91. https://doi.org/10.1111/j.1471-0528.2008.01878.x.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Abbas S., Ihle P., Koster I., Schubert I. Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance-based cohort in Germany. Eur J Obstet Gynecol Reprod Biol. 2012; 160 (1): 79-83. https://doi.org/10.1016/j.ejogrb.2011.09.041.</mixed-citation><mixed-citation xml:lang="en">Abbas S., Ihle P., Koster I., Schubert I. Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance-based cohort in Germany. Eur J Obstet Gynecol Reprod Biol. 2012; 160 (1): 79-83. https://doi.org/10.1016/j.ejogrb.2011.09.041.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rogers P.A.W., D'Hooghe T.M., Fazleabas A., et al. Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci. 2009; 16 (4): 335-46. https://doi.org/10.1177/1933719108330568.</mixed-citation><mixed-citation xml:lang="en">Rogers P.A.W., D'Hooghe T.M., Fazleabas A., et al. Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci. 2009; 16 (4): 335-46. https://doi.org/10.1177/1933719108330568.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Эндометриоз. Всемирная организация здравоохранения. URL: https://www.who.int/ru/news-room/fact-sheets/detail/endometriosis (дата обращения 12.03.2024). Endometriosis. World Health Organization. Available at: https://www.who.int/news-room/fact-sheets/detail/endometriosis (accessed 12.03.2024).</mixed-citation><mixed-citation xml:lang="en">Endometriosis. World Health Organization. Available at: https://www.who.int/news-room/fact-sheets/detail/endometriosis (accessed 12.03.2024).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cho S., Cho H., Nam A., et al. Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis. Fertil Steril. 2008; 90 (6): 2073-9. https://doi.org/10.1016/j.fertnstert.2008.03.061.</mixed-citation><mixed-citation xml:lang="en">Cho S., Cho H., Nam A., et al. Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis. Fertil Steril. 2008; 90 (6): 2073-9. https://doi.org/10.1016/j.fertnstert.2008.03.061.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tokmak A., Yildirim G., Ozta§ E., et al. Use of neutrophil-to-lymphocyte ratio combined with CA-125 to distinguish endometriomas from other benign ovarian cysts. Reprod Sci. 2016; 23 (6): 795-802. https://doi.org/10.1177/1933719115620494.</mixed-citation><mixed-citation xml:lang="en">Tokmak A., Yildirim G., Ozta§ E., et al. Use of neutrophil-to-lymphocyte ratio combined with CA-125 to distinguish endometriomas from other benign ovarian cysts. Reprod Sci. 2016; 23 (6): 795-802. https://doi.org/10.1177/1933719115620494.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Turgut A., Hocaoglu M., Ozdamar O., et al. Could hematologic parameters be useful biomarkers for the diagnosis of endometriosis? Bratisl Lek Listy. 2019; 120 (12): 912-8. https://doi.org/10.4149/BLL_2019_153.</mixed-citation><mixed-citation xml:lang="en">Turgut A., Hocaoglu M., Ozdamar O., et al. Could hematologic parameters be useful biomarkers for the diagnosis of endometriosis? Bratisl Lek Listy. 2019; 120 (12): 912-8. https://doi.org/10.4149/BLL_2019_153.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Seckin B., Ates M.C., Kirbas A., Yesilyurt H. Usefulness of hemato-logical parameters for differential diagnosis of endometriomas in adolescents/young adults and older women. Int J Adolesc Med Health. 2018; 33 (2). https://doi.org/10.1515/ijamh-2018-0078.</mixed-citation><mixed-citation xml:lang="en">Seckin B., Ates M.C., Kirbas A., Yesilyurt H. Usefulness of hemato-logical parameters for differential diagnosis of endometriomas in adolescents/young adults and older women. Int J Adolesc Med Health. 2018; 33 (2). https://doi.org/10.1515/ijamh-2018-0078.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Vigano P., Ottolina J., Sarais V., et al. Coagulation status in women with endometriosis. Reprod Sci. 2018; 25 (4): 559-65. https://doi.org/10.1177/1933719117718273.</mixed-citation><mixed-citation xml:lang="en">Vigano P., Ottolina J., Sarais V., et al. Coagulation status in women with endometriosis. Reprod Sci. 2018; 25 (4): 559-65. https://doi.org/10.1177/1933719117718273.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Yavuzcan A., ^aglar M., Ustun Y., et al. Evaluation of mean platelet volume, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in advanced stage endometriosis with endometrioma. J Turk Ger Gynecol Assoc. 2013; 14 (4): 210-5. https://doi.org/10.5152/jtgga.2013.55452.</mixed-citation><mixed-citation xml:lang="en">Yavuzcan A., ^aglar M., Ustun Y., et al. Evaluation of mean platelet volume, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in advanced stage endometriosis with endometrioma. J Turk Ger Gynecol Assoc. 2013; 14 (4): 210-5. https://doi.org/10.5152/jtgga.2013.55452.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Сорокина А.В. Эндометриоз. Медицинская сестра. 2010; 8: 21-2. Sorokina A.V. Endometriosis. Meditsinskaya sestra / The Nurse. 2010; 8: 21-2 (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Sorokina A.V. Endometriosis. Meditsinskaya sestra / The Nurse. 2010; 8: 21-2 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Мягченкова К.И., Хащенко Е.П., Уварова Е.В. Психоэмоциональные особенности и болевая симптоматика у пациенток, страдающих генитальным эндометриозом в раннем репродуктивном возрасте. Репродуктивное здоровье Детей и подростков. 2021; 17 (2): 41-50. https://doi.org/10.33029/1816-2134-2020-17-2-41-50.</mixed-citation><mixed-citation xml:lang="en">Myagchenkova K.I., Khashchenko E.P., Uvarova E.V. Psychoemotional characteristics and pain symptoms of patients with genital endometriosis in early reproductive age. Reproduktivnoe zdorov'e detey i podrostkov / Pediatric and Adolescent Reproductive Health. 2021; 17 (2): 41-50 (in Russ.). https://doi.org/10.33029/1816-2134-2020-17-2-41-50.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997; 67 (5): 817-21. https://doi.org/10.1016/s0015-0282(97)81391-x.</mixed-citation><mixed-citation xml:lang="en">Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997; 67 (5): 817-21. https://doi.org/10.1016/s0015-0282(97)81391-x.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Manolescu B.N., Berteanu M., Dumitru L., et al. Dynamics of inflammatory markers in post-acute stroke patients undergoing rehabilitation. Inflammation. 2011; 34 (6): 551-8. https://doi.org/10.1007/s10753-010-9262-8.</mixed-citation><mixed-citation xml:lang="en">Manolescu B.N., Berteanu M., Dumitru L., et al. Dynamics of inflammatory markers in post-acute stroke patients undergoing rehabilitation. Inflammation. 2011; 34 (6): 551-8. https://doi.org/10.1007/s10753-010-9262-8.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Yeh T.T., Hsieh Y.W., Wu C.Y., et al. A preliminary investigation of the association of sleep with inflammation and oxidative stress biomarkers and functional outcomes after stroke rehabilitation. Sci Rep. 2017; 7 (1): 8634. https://doi.org/10.1038/s41598-017-08931-w.</mixed-citation><mixed-citation xml:lang="en">Yeh T.T., Hsieh Y.W., Wu C.Y., et al. A preliminary investigation of the association of sleep with inflammation and oxidative stress biomarkers and functional outcomes after stroke rehabilitation. Sci Rep. 2017; 7 (1): 8634. https://doi.org/10.1038/s41598-017-08931-w.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Roh J.S., Sohn D.H. Damage-associated molecular patterns in inflammatory diseases. Immune Netw. 2018; 18 (4): e27. https://doi.org/10.4110/in.2018.18.e27.</mixed-citation><mixed-citation xml:lang="en">Roh J.S., Sohn D.H. Damage-associated molecular patterns in inflammatory diseases. Immune Netw. 2018; 18 (4): e27. https://doi.org/10.4110/in.2018.18.e27.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ronchetti L., Terrenato I., Ferretti M., et al. Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer. J Exp Clin Cancer Res. 2022; 41 (1): 151. https://doi.org/10.1186/s13046-022-02359-5.</mixed-citation><mixed-citation xml:lang="en">Ronchetti L., Terrenato I., Ferretti M., et al. Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer. J Exp Clin Cancer Res. 2022; 41 (1): 151. https://doi.org/10.1186/s13046-022-02359-5.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Слуханчук Е.В., Бицадзе В.О., Солопова А.Г. и др. Вклад внеклеточных ловушек нейтрофилов в протромботическое состояние и прогрессию опухоли у онкогинекологических пациенток. Акушерство, гинекология и репродукция. 2023; 17 (1): 53-64. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2023.385.</mixed-citation><mixed-citation xml:lang="en">Slukhanchuk E.V., Bitsadze V.O., Solopova A.G., et al. An impact of neutrophil extracellular traps to the prothrombotic state and tumor progression in gynecological cancer patients. Obstetrics, Gynecology and Reproduction. 2023; 17 (1): 53-64 (in Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2023.385.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Слуханчук Е.В., Бицадзе В.О., Солопова А.Г. и др. Внеклеточные ловушки нейтрофилов как маркеры тромбовоспаления в патогенезе злокачественных новообразований женских половых органов и молочной железы. Акушерство, гинекология и репродукция. 2022; 16 (4): 426-37. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2022.335.</mixed-citation><mixed-citation xml:lang="en">Slukhanchuk E.V., Bitsadze V.O., Solopova A.G., et al. Neutrophil extracellular traps as markers of thromboinflammation in the pathogenesis of female genital tract and breast malignant neoplasms. Obstetrics, Gynecology and Reproduction. 2022; 16 (4): 426-37 (in Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2022.335.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
